Stories from Kobe

Sysmex Europe SE

2

Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.

Sysmex Europe SE

Strengthening the Direct Sales and Service System for Business Expansion in Italy

Sysmex Europe SE

3

Sysmex Europe Launches the UF-1500 Fully Automated Urine Particle Analyser

Sysmex Inostics GmbH

Sysmex obtains Japanese manufacturing and marketing approval for the first blood-based RAS mutation testing for colorectal cancer

Kobe, Japan (ots) - Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM(TM) RAS CRC Kit, used for blood-based circulating tumor DNA (ctDNA) molecular testing of mutations in the RAS gene for advanced colorectal cancer patients. With clinically-validated high sensitivity and ...